Investing Profile

Jay Lichter

VCInvestor

Managing Director at Avalon Ventures

Your Intro Paths to Jay Lichter

Signal uses Gmail to reveal intro paths. Email content is never read.

Find Jay Lichter on

Current Investing Position

Investment Range

$1M - $10.0M

Sweet Spot

$5.0M

Investments On Record

Current Fund Size

$116M

Jay Lichter is on these Sector & Stage Rankings

Jay Lichter's Investments On Record (7)

Company	StageDateRound Size	Total Raised
Enlaza Therapeutics	Series AApr 2024$100M SeedOct 2022$61M	$160M
Co-investors: Stephen Squinto (OrbiMed), James N. Topper (Frazier Healthcare Partners), Marcos Milla (Samsara BioCapital)
Arialys Therapeutics	SeedSep 2023$58M	$58M
Janux Therapeutics	Series BApr 2021$130M Series AMar 2021$56M	$180M
Co-investors: Peter Thompson (OrbiMed), Jake Simson (RA Capital)
AristaMD	Series BMar 2020$18M Series AJul 2016$11M	$35M
Co-investors: Payal Agrawal Divakaran (.406 Ventures), John Kuelper (Ascension Ventures)
Avelas Biosciences	Series CAug 2016$20M Series BSep 2014$7M Series BJan 2014$7M Series ADec 2012$8M	$42M
Co-investors: Kevin Kinsella (Avalon Ventures)
Otonomy	Series DApr 2014$49M Series CSep 2013$46M Series AJun 2010$10M	$180M
Co-investors: Chau Khuong (OrbiMed), Bill Harrington (Osage University Partners), Niall O’Donnell (RiverVest), John McKearn (RiverVest), Peter Bisgaard (Pivotal bioVenture Partners), Brian Dovey (Domain Associates), Heather Preston
Aratana Therapeutics	Series BDec 2011$15M Series AJan 2011$20M	$35M
Co-investors: Steven St. Peter (T1D Fund), Ron Meeusen (Cultivian Sandbox Ventures)